There is starting to be a steady buzz across the web about Cellceutix Corporation (OTCBB: CTIX) and its novel cancer drug, Kevetrin™. For starters, the p53-activating drug is on tap to begin dosing patients with solid tumors any day now in clinical trials at the vaunted Harvard University’s Dana-Farber Cancer Institute and partner Beth Israel Deaconess Medical Center. Second, Cellceutix has reported that Beth Israel is sponsoring independent trials on Kevetrin in combination with Pfizer (NYSE: PFE) multikinase inhibitor drugs as potential new therapies for renal cancer and melanoma. Now, this weekend, the company said that a major university in Europe has approached them to sponsor and host additional research on Kevetrin targeting leukemia in combination with drugs from one of the world’s biggest pharmaceutical companies.
Big biotechs have and insatiable thirst right now for new drugs as the patent cliff has dampened revenues for many and pipelines are thin for novel drug candidates. Cancer is of particular interest as the revenue stream for a successful cancer drug can easily tally into the billions annually. Additionally, a recent report from the Tufts Center for the Study of Drug Development found that cancer drugs are getting faster approval times at the FDA than all other disease categories combined; giving the already in-demand drugs even greater appeal to big pharma. According to Fierce Biotech , “[the] center concluded that cancer drugs claimed a growing share of the orphan drug market as the total time it requires to take a fast-track drug through development to an approval shrunk by an impressive 1.7 years over the past decade.”
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Bringing Birth Registration into the 21st Century Alright, let's cut through the fog. If you ask most folks about their birth certificates, you'd hear tales of tattered paper and government office runs. What if I told you this vital piece of paper could be reborn altogether? That's what the Secure Identity Alliance is up to with their OSIA Live Interoperability Demo at...
Quarterly Results: The Numbers to Watch Alright, here's the scoop from MCAP Inc.: they just tossed their hat in the quarterly earnings ring, flexing a third quarter EPS of $0.15 a share. Not exactly champagne-popping numbers, but hey, let's not throw out the party favors just yet. Revenues rolled in at a neat $26.7 million, with EBITDA tagging along at $5.2 million. So,...
Truelink's Big Move in Creative Marketing I don't throw around the word 'synergy' lightly, but this Truelink Capital move has me grudgingly utter it. Picture this: GES, a big dog in event marketing, just grabbed CSG Creative, a firm with its teeth sunk deep into association and event organizer marketing. It sounds like the kind of match you only find lurking in the fancy...
Sunday Showdown at ACR: A Massive Poker Feast Kicking off the action on November 8, ACR Poker brings its Online Super Series (OSS) into the spotlight, and listen up—there's a cool $20 million spread on the table through November 24. What's got people really tuned in, though, is the mix of big stakes, high tension events, and a shot at paradise over in the Bahamas....
Welcome to the Future of Amphibious Flight You ever wonder when we'd get past seeing traditional planes stuck at runways? Well, Maxwell Aircraft just fired a hefty shot across the bow with their M1 Hybrid amphibious model. This ain't your run-of-the-mill crate with wings; it's redefining what these birds can do, particularly if you're eyeing remote areas or water-based...
CMS's Move: A New Payment Pathway You don't expect bureaucrats to stir things up, but check this out: the CMS 2027 Physician Fee Schedule has done just that by setting a non-facility (office) payment rate for CPT code 27279. This code covers those fiddly, minimally invasive sacroiliac (SI) joint procedures, where you engage bone and get down to real orthopedic business....
Breaking New Ground in Utah Alright, letting another workspace provider muscle into a new territory isn't groundbreaking anymore, but with Expansive breaking into Salt Lake City, there's more than meets the eye. We're talking about expanding not just geographically but also strategically in Utah's fertile grounds—characterized by a booming local economy and escalating...
Navigating Oil and Gas with Kevin K. Thibeau Investors, buckle up. The world of oil and gas ain't for the faint-hearted! We’re talking about an industry that, when you strike it right, can flow like a Texas gusher—but a misstep can leave your portfolio drier than the Mojave. Kevin K. Thibeau, the commander at Wheeler Resource Recovery since back in 2014, lays out the...
Kicking Off Ajman's Media Innovation Push Forget the stale conferences; Ajman is putting its chips on the table with the inaugural Ajman Media Forum 2026. Set to ignite on November 18 and 19 under the catchy theme 'Who Owns the Signal?,' this two-day brain fest takes media transformation by the horns. They're not just talking; they're set to weave emerging tech,...
Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...
Exciting Developments from Landmark Homes Landmark Homes, a well-respected name in the homebuilding industry, has unveiled an exciting plan for expansion that aims to enhance lifestyle options. This initiative brings forth a new type of product alongside thoughtfully designed floor plans that embody modern living. Potential homeowners will have the chance to discover...
CCC Intelligent Solutions Implements New Share Repurchase Program Recently, CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCC), a recognized provider of SaaS platforms within the insurance sector, announced an exciting development that is expected to greatly benefit its stakeholders. This announcement highlights a new share repurchase program authorized by the...
XPENG Reports Outstanding Vehicle Delivery Performance in November XPENG Inc., known for its innovative approach in the smart electric vehicle sector, has revealed impressive vehicle delivery statistics for November. The company delivered a remarkable total of 30,895 Smart EVs during this period, marking an extraordinary 54% increase compared to last year. This growth...
STAK Inc. Successfully Completes Initial Public Offering In a significant milestone for STAK Inc. (Nasdaq: STAK), the company has officially announced the successful closing of its initial public offering (IPO), marking a pivotal moment in its growth strategy. Specializing in the manufacturing and sale of oilfield-related production and maintenance equipment, STAK Inc. is...
Scalefusion Broadens Its Management Platform with ChromeOS ProMobi Technologies has revealed an exciting new development regarding Scalefusion, its premier unified endpoint management (UEM) solution. Scalefusion has recently added support for ChromeOS device management, taking another significant step towards creating a versatile and robust multi-OS management platform...
